This Site All Sites

Find a Program

Find a Lab

Message from the Director

Sandy Feng, M.D., Ph.D.

Associate Professor of Surgery
Director, Abdominal Transplant Fellowship Program

Make a Gift

A gift to the Department of Surgery helps us discover new treatments and cures.

 

Select by Date:

Dr. Sang-Mo Kang Appears in Documentary by Indie pop star Pat Spurgeon

San Francisco International Film Festival - May 01, 2009

Thirteen years ago, Pat Spurgeon of the indie pop band Rogue Wave recieved a kidney transplant. Unfortunately, just as the band started to take off, the kidney began to fail. The feature documentary "D Tour" chronicles Pat's experience as a UCSF kidney patient  including his search for a living organ donor. The film also features Dr. Sang-Mo Kang of the UCSF Division of Transplantation, the surgeon who took care of Pat.  * Image of Pat Spurgeon courtesy of "The independent, SF"  and provided under a creative commons  attribution license.

Dr. Sandy Feng Updates Progress in Immunosupression for Liver Transplantation

UCTelevision - Jan 19, 2009

Dr. Sandy Feng, Associate Professor of Surgery and Director of the UCSF Abdominal Transplant Fellowship Program. presents an update on the progress in immunosupression for liver transplantation. Series: UCSF Transplant Update [1/2009] [Health and Medicine] [Professional Medical Education] [Show ID: 15737].

Transplantation: The Cerberus of the 20th Century

UCTV - Jan 05, 2009

"Dr. Nancy Ascher presents The Osher Center for Integrative Medicine's mini-med lecture on transplantation. Explore how new technology may affect the future of transplantation."

Celebrating 45 Years of Transplantation...and Growing

University of California, San Francisco - Oct 01, 2008

"In September of 2008, the UCSF Department of Surgery celebrated 45 years as a world leader in transplantation with a week-long series of events including a Carnival, a VIP dinner and a fitness lecture.  In 1969, surgeons performed the first transplantation procedure at UCSF, spurring a series of unprecedented operations and discoveries both at UCSF and world-wide."

Organs for Sale?

Nancy Ascher, MD, PhD on NPR's Forum with Michael Krasny - Sep 22, 2008

"Each day in the U.S., 19 people die waiting for donated organs. To help increase supply, some health experts and economists want to legalize the market for human organs. We take up the issue with a panel of experts."

International Stem Cell Corporation's Human Parthenogenetic Stem Cells to be used in the Development of Treatments for Liver Disease

Business Wire - San Francisco,CA,USA - May 14, 2008

"International Stem Cell Corporation  announced today that its human parthenogenetic stem cell lines will be used in studies aimed at creating liver cells to treat human liver disease. ......Holger Willenbring, MD, UCSF assistant professor of surgery, will direct the research. "The fact that Dr. Willenbring and the University of California at San Francisco are testing the ability of ISCO's human parthenogenetic stem cells to form liver cells is a strong validation of their potential value in creating therapeutic cells that have significant immune rejection advantages and significant ethical advantages," said Jeffrey Janus, ISCO's President."

Great Discoveries: UCSF Organ Transplant Experience Discussed by Dr. Nancy Ascher

UCTV - Mar 13, 2008

Dr. Nancy Ascher, chair of the UCSF Department of Surgery, has devoted her career to organ transplants and transplant research. Learn more about organ transplant at UCSF Medical Center, a service that began in the 1960s. Series: "UCSF Mini Medical School for the Public" [6/2006] [Health and Medicine] [Professional Medical Education] [Show ID: 11683]

Survival rates exceed national averages for UCSF heart, liver and lung transplant programs

UCSF News - Feb 29, 2008

"One-year survival rates for patients receiving heart, liver and lung transplants at UCSF Medical Center exceed national averages at statistically significant levels, according to new data compiled by the Scientific Registry of Transplant Recipients (SRTR)."

UCSF Surgeons Discuss Embryonic Stem Cells as Treatment of Liver Disease on PBS NewsHour

PBS NewsHour with Jim Lehrer - Oct 08, 2007

Dr. Nancy Ascher and Dr. Holger Willenbring were interviewed by PBS NewsHour correspondent Spencer Michels about the transformation of embryonic stem cells into new liver cells as a treatment for patients.

"The Wait for Life" Highlights Organ Sharing Debate, with UCSF's Liver Transplant Service at the Center

UCSF Today, CA - Sep 19, 2006

"A difficult conundrum for the nation's transplant patients was aired September 22 when the news program California Connected featured UCSF's Liver Transplant Program. The story, produced by Jon Dann for public television stations KQED and KCET, highlights the difficult choices that patients, families and doctors face because of the shortage of donated organs for transplantation."

A day in the life of a husband and wife liver transplant team

San Francisco Chronicle, CA - Dec 18, 2005

"Of all the things for a married couple to bicker about, Nancy Ascher and John Roberts have hit on a first -- a pulsing human liver. To be precise, they are standing forehead to forehead with a man splayed out between them. Roberts wants more of his liver to take next door to a waiting recipient. Ascher wants more of it left behind for the donor's recovery."

Improving the outlook for simultaneous pancreas-kidney transplants

UCSF Diabetes Center - San Francisco, CA - Feb 01, 2005
"The body's rejection of transplanted organs and tissues is an unfortunate risk of transplant surgery. Historically, rejection rates in a simultaneous pancreas-kidney (SPK) transplant have been as high as 80% and, in 2001, averaged nearly 20%. ........Diabetes Center surgeons Peter Stock, (left) and Chris Freise (right) have been pioneering new methods of immunosuppression for SPK transplants that do not rely upon steroids, with great success...... "

Read Full Diabetes Center Article

Read Jourunal Article in American Journal of Transplantation

The Domino Effect - Woman gets new liver, gives her old one to save another life

San Francisco Chronicle, CA - Aug 22, 2000

"The next day, surgeons at the University of California at San Francisco performed a rare liver transplant called a ``domino transplant,'' the first in the Bay Area and one of just a handful done in the United States. ........................Her choice was to have a liver that will give her a disease in 30 years, or die of cancer in the next year,'' said Dr. Ryutaro Hirose (pictured left), the surgeon for both transplants. ``She jumped at the chance, and most people would.''

 Email Page  
Send Email to *: (You can include up to four email addresses, separated by a comma)
Your Email Address *:
Email Subject *:
Comment: (maximum of 200 characters)

* required fields
" />